After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Award
Reported value range
Not reported

Lanfear Dennis M President & CEO

Transaction date May 29, 2026
Public filing date Jun 2, 2026
Filing lag Filed 4 days later

CHRS daily price context

Close on/before transaction
$1.59 May 29, 2026
First close after public filing
-- Unavailable
30-day return after filing
-- Through Unavailable

Source details

Reported owner
Not disclosed
Source asset code
Derivative
Security
Stock Option (Right to Buy) on Common Stock
Quantity / price
200,000 shares
SEC ownership
Direct
Transaction code
A
Form
4
Filing identifier
0001104659-26-069621
Filing cohort

Transactions in this filing

Showing 15 of 18
Trades
18
Issuers
1
Estimated value
Not reported
Buys / sales
0 / 0
Transactions reported in the same official filing
Issuer Transaction Traded Value
Coherus Oncology, Inc. CHRS Disposition May 29, 2026 Not reported
Coherus Oncology, Inc. CHRS Disposition May 29, 2026 Not reported
Coherus Oncology, Inc. CHRS Disposition May 29, 2026 Not reported
Coherus Oncology, Inc. CHRS Disposition May 29, 2026 Not reported
Coherus Oncology, Inc. CHRS Disposition May 29, 2026 Not reported
Coherus Oncology, Inc. CHRS Disposition May 29, 2026 Not reported
Coherus Oncology, Inc. CHRS Disposition May 29, 2026 Not reported
Coherus Oncology, Inc. CHRS Disposition May 29, 2026 Not reported
Coherus Oncology, Inc. CHRS Disposition May 29, 2026 Not reported
Coherus Oncology, Inc. CHRS Current Award May 29, 2026 Not reported
Coherus Oncology, Inc. CHRS Award May 29, 2026 Not reported
Coherus Oncology, Inc. CHRS Award May 29, 2026 Not reported
Coherus Oncology, Inc. CHRS Award May 29, 2026 Not reported
Coherus Oncology, Inc. CHRS Award May 29, 2026 Not reported
Coherus Oncology, Inc. CHRS Award May 29, 2026 Not reported